Synaptic pruning drugs could offer therapeutic strategies for autism and schizophrenia
Researchers at SUNY Downstate Medical Center (Brooklyn, NY, USA) have identified drugs that trigger synaptic pruning, which could be utilized in drug therapies for disorders with abnormal numbers of synapses, such as autism and schizophrenia.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.